| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6150837 | Contemporary Clinical Trials | 2015 | 6 Pages |
Abstract
Considering the poor efficacy of available drugs in chemotherapy-induced neuropathic pain, dextromethorphan may be a valuable therapeutic option. Pharmacogenetics may provide predictive factors of dextromethorphan response in patients suffering from breast cancer.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Elodie Martin, Véronique Morel, Dominique Joly, Christine Villatte, Noémie Delage, Claude Dubray, Bruno Pereira, Gisèle Pickering,